"Myosin-Light-Chain Phosphatase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phosphoprotein phosphatase that is specific for MYOSIN LIGHT CHAINS. It is composed of three subunits, which include a catalytic subunit, a myosin binding subunit, and a third subunit of unknown function.
- Myosin-Light-Chain Phosphatase
- Phosphatase, Myosin-Light-Chain
- Myosin Light Chain Phosphatase
- Myosin Phosphatase
- Phosphatase, Myosin
- Calponin Phosphatase
- Phosphatase, Calponin
Smooth Muscle Phosphatase-II
- Smooth Muscle Phosphatase-II
- Muscle Phosphatase-II, Smooth
- Phosphatase-II, Smooth Muscle
- Smooth Muscle Phosphatase II
Below are MeSH descriptors whose meaning is more general than "Myosin-Light-Chain Phosphatase".
Below are MeSH descriptors whose meaning is more specific than "Myosin-Light-Chain Phosphatase".
This graph shows the total number of publications written about "Myosin-Light-Chain Phosphatase" by people in this website by year, and whether "Myosin-Light-Chain Phosphatase" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Myosin-Light-Chain Phosphatase" by people in Profiles.
A self-organized biomechanical network drives shape changes during tissue morphogenesis. Nature. 2015 Aug 20; 524(7565):351-5.
Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. J Sex Med. 2013 Jun; 10(6):1502-15.
Endothelial barrier disruption and recovery is controlled by substrate stiffness. Microvasc Res. 2013 May; 87:50-7.
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2011 Oct; 31(10):2353-9.
ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric artery. J Muscle Res Cell Motil. 2011 Sep; 32(2):65-76.
Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res. 2011 Feb 01; 71(3):655-60.
ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res. 2010 Jan; 79(1):56-62.
Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res. 2009 Feb 27; 1257:89-93.
GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2006 Mar; 290(3):L540-8.
Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J Cell Physiol. 2005 Sep; 204(3):934-47.